Acumen Pharmaceuticals, Inc.(ABOS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ABOS Acumen Pharmaceuticals, Inc.

盘后交易 02-26 19:06:42 EST

2.83

+0.05

+1.80%

盘后2.83

+0.000.00%

17:59 EST

最高2.89	最低2.75	成交量20.13万
今开2.80	昨收2.78	日振幅4.86%
总市值1.71亿	流通市值9,319万	总股本6,057万
成交额56.69万	换手率0.61%	流通股本3,293万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ABOS","market":"US","secType":"STK","nameCN":"Acumen Pharmaceuticals, Inc.","latestPrice":2.83,"timestamp":1772139600000,"preClose":2.78,"halted":0,"volume":201285,"hourTrading":{"tag":"盘后","latestPrice":2.83,"preClose":2.83,"latestTime":"17:59 EST","volume":597,"amount":1689.51,"timestamp":1772146752656,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.017985611510791463,"floatShares":32929494,"shares":60573425,"eps":-2.206395,"marketStatus":"盘后交易","change":0.05,"latestTime":"02-26 19:06:42 EST","open":2.8,"high":2.885,"low":2.75,"amount":566896.779351,"amplitude":0.048561,"askPrice":2.97,"askSize":225,"bidPrice":2.69,"bidSize":28,"shortable":3,"etf":0,"ttmEps":-2.206395,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1772154000000},"marketStatusCode":4,"adr":0,"listingDate":1625112000000,"exchange":"NASDAQ","adjPreClose":2.78,"preHourTrading":{"tag":"盘前","latestPrice":2.7212,"preClose":2.78,"latestTime":"09:10 EST","volume":250,"amount":680.3000000000001,"timestamp":1772115002045,"change":-0.0588,"changeRate":-0.021151,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":2.83,"preClose":2.83,"latestTime":"17:59 EST","volume":597,"amount":1689.51,"timestamp":1772146752656,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.908194,"impliedVol":1.3341,"impliedVolPercentile":0.7211},"requestUrl":"/m/hq/s/ABOS","defaultTab":"news","newsList":[{"id":"2610664799","title":"Acumen Pharmaceuticals, Inc.盘中异动 早盘大幅跳水5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610664799","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610664799?lang=zh_cn&edition=full","pubTime":"2026-02-09 22:32","pubTimestamp":1770647543,"startTime":"0","endTime":"0","summary":"北京时间2026年02月09日22时32分，Acumen Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.42%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一种新型疾病缓解方法，以针对其认为是阿尔茨海默病的关键潜在原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209223223a6e68deb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209223223a6e68deb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABOS","BK4539"],"gpt_icon":0},{"id":"2603647244","title":"Acumen Pharmaceuticals, Inc.盘中异动 大幅拉升6.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603647244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603647244?lang=zh_cn&edition=full","pubTime":"2026-01-14 23:08","pubTimestamp":1768403306,"startTime":"0","endTime":"0","summary":"北京时间2026年01月14日23时08分，Acumen Pharmaceuticals, Inc.股票出现波动，股价大幅拉升6.36%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一种新型疾病缓解方法，以针对其认为是阿尔茨海默病的关键潜在原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114230826a71ac332&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114230826a71ac332&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABOS","BK4539","BK4139"],"gpt_icon":0},{"id":"1184366581","title":"Acumen Pharmaceuticals展示优化脑部输送技术及第二阶段Altitude-AD临床试验的招募策略","url":"https://stock-news.laohu8.com/highlight/detail?id=1184366581","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184366581?lang=zh_cn&edition=full","pubTime":"2025-12-02 21:01","pubTimestamp":1764680474,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals展示优化脑部输送技术及第二阶段Altitude-AD临床试验的招募策略","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ABOS","BK4139"],"gpt_icon":0},{"id":"1148597972","title":"Acumen Pharmaceuticals宣布早期阿尔茨海默病患者的第二阶段开放标签延续研究首名参与者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1148597972","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148597972?lang=zh_cn&edition=full","pubTime":"2025-11-17 21:02","pubTimestamp":1763384530,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals宣布早期阿尔茨海默病患者的第二阶段开放标签延续研究首名参与者给药","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS","BK4139","BK4539"],"gpt_icon":0},{"id":"2584695419","title":"Acumen Pharmaceuticals, Inc.2025财年第三财季实现净利润-26.45百万美元，同比增加11.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584695419","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584695419?lang=zh_cn&edition=full","pubTime":"2025-11-17 00:02","pubTimestamp":1763308975,"startTime":"0","endTime":"0","summary":"11月17日，Acumen Pharmaceuticals, Inc.公布财报，公告显示公司2025财年第三财季净利润为-26.45百万美元，同比增加11.15%；其中营业收入为0.00美元，每股基本收益为-0.44美元。从资产负债表来看，Acumen Pharmaceuticals, Inc.总负债49.05百万美元，其中短期债务3.74百万美元，资产负债比为0.03，流动比率为0.07。机构评级：截至2025年11月17日，当前有4家机构对Acumen Pharmaceuticals, Inc.目标价做出预测，其中目标均价为6.75美元，其中最低目标价为4.00美元，最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117000318950817f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117000318950817f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABOS"],"gpt_icon":0},{"id":"1182901857","title":"Acumen Pharmaceuticals, Inc.：预计非临床数据将支持Ebd疗法的开发，时间定于2026年初","url":"https://stock-news.laohu8.com/highlight/detail?id=1182901857","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182901857?lang=zh_cn&edition=full","pubTime":"2025-11-12 20:19","pubTimestamp":1762949956,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals, Inc.：预计非临床数据将支持Ebd疗法的开发，时间定于2026年初","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ABOS","BK4139"],"gpt_icon":0},{"id":"2581207963","title":"Acumen Pharmaceuticals, Inc.盘中异动 下午盘急速下跌5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581207963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581207963?lang=zh_cn&edition=full","pubTime":"2025-11-07 03:53","pubTimestamp":1762458809,"startTime":"0","endTime":"0","summary":"北京时间2025年11月07日03时53分，Acumen Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.42%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.98%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一种新型疾病缓解方法，以针对其认为是阿尔茨海默病的关键潜在原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110703532994f3ebd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110703532994f3ebd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABOS","BK4539","BK4139"],"gpt_icon":0},{"id":"2578575437","title":"Acumen Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.21%报2.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578575437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578575437?lang=zh_cn&edition=full","pubTime":"2025-10-24 21:59","pubTimestamp":1761314387,"startTime":"0","endTime":"0","summary":"北京时间2025年10月24日21时59分，Acumen Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.21%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一种新型疾病缓解方法，以针对其认为是阿尔茨海默病的关键潜在原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024215947974094c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024215947974094c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABOS","BK4139","BK4539"],"gpt_icon":0},{"id":"2577334888","title":"Acumen Pharmaceuticals, Inc.盘中异动 股价大跌5.02%报1.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577334888","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577334888?lang=zh_cn&edition=full","pubTime":"2025-10-22 23:56","pubTimestamp":1761148597,"startTime":"0","endTime":"0","summary":"北京时间2025年10月22日23时56分，Acumen Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.02%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.50%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一种新型疾病缓解方法，以针对其认为是阿尔茨海默病的关键潜在原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102223563794d80a60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102223563794d80a60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABOS","BK4539","BK4139"],"gpt_icon":0},{"id":"2575760104","title":"Acumen Pharmaceuticals, Inc.盘中异动 早盘急速下挫5.15%报2.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575760104","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575760104?lang=zh_cn&edition=full","pubTime":"2025-10-15 23:18","pubTimestamp":1760541515,"startTime":"0","endTime":"0","summary":"北京时间2025年10月15日23时18分，Acumen Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.15%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.99%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一种新型疾病缓解方法，以针对其认为是阿尔茨海默病的关键潜在原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015231836972feea9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015231836972feea9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABOS","BK4139","BK4539"],"gpt_icon":0},{"id":"2572583585","title":"Acumen Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.05%报1.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572583585","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572583585?lang=zh_cn&edition=full","pubTime":"2025-09-30 21:53","pubTimestamp":1759240403,"startTime":"0","endTime":"0","summary":"北京时间2025年09月30日21时53分，Acumen Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.05%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Scisparc Ltd.、Anaptysbio, Inc.、Zura Bio Limited涨幅较大，Scisparc Ltd.、Qualigen Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为1490.38%、276.86%、254.84%，振幅较大的相关个股有Scisparc Ltd.、Geovax Labs, Inc.、Protagenic Therapeutics, Inc.，振幅分别为25.55%、20.14%、17.39%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一种新型疾病缓解方法，以针对其认为是阿尔茨海默病的关键潜在原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930215323954e5d5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930215323954e5d5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","ABOS"],"gpt_icon":0},{"id":"2516654373","title":"Acumen Pharmaceuticals, Inc.盘中异动 大幅下挫5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516654373","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516654373?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:05","pubTimestamp":1741025113,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时05分，Acumen Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.47%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040205139637dded&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040205139637dded&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","ABOS"],"gpt_icon":0},{"id":"2514862334","title":"Acumen Pharmaceuticals, Inc.盘中异动 股价大跌5.22%报1.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514862334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514862334?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:07","pubTimestamp":1740600466,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时07分，Acumen Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.22%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.77%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227040746a2554143&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227040746a2554143&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABOS","BK4539","BK4139"],"gpt_icon":0},{"id":"2514011121","title":"Acumen Pharmaceuticals, Inc.盘中异动 大幅下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514011121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514011121?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:34","pubTimestamp":1740501272,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时34分，Acumen Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.04%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226003432abdc9b22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226003432abdc9b22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","ABOS"],"gpt_icon":0},{"id":"2511579498","title":"Acumen Pharmaceuticals, Inc.盘中异动 快速拉升5.11%报1.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511579498","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511579498?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:04","pubTimestamp":1739473464,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日03时04分，Acumen Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.11%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.08%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502140304249621f034&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502140304249621f034&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ABOS","BK4139"],"gpt_icon":0},{"id":"2510387221","title":"Acumen Pharmaceuticals, Inc.盘中异动 股价大跌5.04%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510387221","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510387221?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:36","pubTimestamp":1739284571,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时36分，Acumen Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.04%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.93%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223612abcb073b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223612abcb073b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","ABOS"],"gpt_icon":0},{"id":"2505773298","title":"Acumen Pharmaceuticals, Inc.盘中异动 快速上涨5.52%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505773298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505773298?lang=zh_cn&edition=full","pubTime":"2025-01-23 01:01","pubTimestamp":1737565281,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日01时01分，Acumen Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.52%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123010121a22bd190&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123010121a22bd190&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABOS","BK4139","BK4539"],"gpt_icon":0},{"id":"2504914040","title":"Acumen Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.26%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504914040","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504914040?lang=zh_cn&edition=full","pubTime":"2025-01-17 00:15","pubTimestamp":1737044139,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日00时15分，Acumen Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.26%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117001540a224780a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117001540a224780a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABOS","BK4539"],"gpt_icon":0},{"id":"2503647436","title":"Acumen Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.45%报1.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503647436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503647436?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:38","pubTimestamp":1736951935,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时38分，Acumen Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.45%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522385598673d5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522385598673d5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","ABOS"],"gpt_icon":0},{"id":"2501775811","title":"Acumen Pharmaceuticals, Inc.盘中异动 早盘大幅跳水5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501775811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501775811?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:50","pubTimestamp":1736347818,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时50分，Acumen Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.34%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108225018985f7c2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108225018985f7c2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABOS","BK4539"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.acumenpharm.com","stockEarnings":[{"period":"1week","weight":0.0651},{"period":"1month","weight":0.3365},{"period":"3month","weight":0.4256},{"period":"6month","weight":1.0441},{"period":"1year","weight":1.0746},{"period":"ytd","weight":0.3175}],"compareEarnings":[{"period":"1week","weight":0.01},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0198},{"period":"6month","weight":0.0746},{"period":"1year","weight":0.1664},{"period":"ytd","weight":0.0165}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Acumen Pharmaceuticals, Inc.于1996年在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，正在开发一种新的疾病改善方法，以针对该公司认为是阿尔茨海默病或AD的关键根本原因。阿尔茨海默病是一种大脑进行性神经退行性疾病，会导致记忆和认知功能丧失，最终导致死亡。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.018698},{"month":2,"riseRate":0.6,"avgChangeRate":0.044914},{"month":3,"riseRate":0,"avgChangeRate":-0.190829},{"month":4,"riseRate":0.25,"avgChangeRate":-0.059929},{"month":5,"riseRate":0.25,"avgChangeRate":0.002499},{"month":6,"riseRate":0.5,"avgChangeRate":0.065932},{"month":7,"riseRate":1,"avgChangeRate":0.316611},{"month":8,"riseRate":0.4,"avgChangeRate":-0.036235},{"month":9,"riseRate":0.4,"avgChangeRate":0.088763},{"month":10,"riseRate":0.4,"avgChangeRate":-0.092058},{"month":11,"riseRate":0.2,"avgChangeRate":-0.138923},{"month":12,"riseRate":0.4,"avgChangeRate":0.05729}],"exchange":"NASDAQ","name":"Acumen Pharmaceuticals, Inc.","nameEN":"Acumen Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Acumen Pharmaceuticals, Inc.(ABOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Acumen Pharmaceuticals, Inc.(ABOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Acumen Pharmaceuticals, Inc.,ABOS,Acumen Pharmaceuticals, Inc.股票,Acumen Pharmaceuticals, Inc.股票老虎,Acumen Pharmaceuticals, Inc.股票老虎国际,Acumen Pharmaceuticals, Inc.行情,Acumen Pharmaceuticals, Inc.股票行情,Acumen Pharmaceuticals, Inc.股价,Acumen Pharmaceuticals, Inc.股市,Acumen Pharmaceuticals, Inc.股票价格,Acumen Pharmaceuticals, Inc.股票交易,Acumen Pharmaceuticals, Inc.股票购买,Acumen Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Acumen Pharmaceuticals, Inc.(ABOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Acumen Pharmaceuticals, Inc.(ABOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}